<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Composite tumor with pheochromocytoma and immature neuroblastoma: report of two cases with cytogenetic analysis and discussion of current terminology.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Composite tumor with pheochromocytoma and immature neuroblastoma: report of two cases with cytogenetic analysis and discussion of current terminology." class="clickable-image" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614909/bin/428_2017_2225_Fig1_HTML.jpg"/> </div> <div class="text-side"> <h1>Composite tumor with pheochromocytoma and immature neuroblastoma: report of two cases with cytogenetic analysis and discussion of current terminology.</h1> <p>Patient 1 was a 57-year-old male who was incidentally discovered to have a left adrenal mass lesion on a CT scan performed for hematuria (a). On cross section, the tumor consisted of a demarcated lesion arising within the adrenal gland (b) (size bar 1Â cm). H&amp;E images show a biphasic lesion (c) with nested areas of pheochromocytoma (d) that includes S100 positive sustentacular cells (e). Other areas show neuropil-type stroma with immature small neuroblastic cells and rare ganglion cells (f). PGP9.5 and chromogranin corresponding to the same area seen in panel C show distinct labeling in the two components. The neuroblastoma component is more strongly positive for PGP9.5 (g) while chromogranin (CMG) expression is largely restricted to the pheochromocytoma component of the tumor (h)</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/28864906/" target="_blank">28864906</a></p><p>Type: Premalignant/Malignant, Category: Neural or neuroendocrine</p>
</div> </div></div></body></html>